We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+9.77%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.54B
AUM Growth
-$135M
Cap. Flow
-$214M
Cap. Flow %
-13.95%
Top 10 Hldgs %
25.05%
Holding
1,512
New
379
Increased
290
Reduced
289
Closed
425

Top Buys

Rank Stock Value
1
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$10.9M
2
ARNC
Arconic Corporation
ARNC
+$7.33M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$7.14M
4
NTES icon
NetEase
NTES
+$7.01M
5
MU icon
Micron Technology
MU
+$6.95M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$65.4M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$62.2M
3
LI icon
Li Auto
LI
+$29.4M
4
CVII
Churchill Capital Corp VII Class A Common Stock
CVII
+$15.1M
5
BABA icon
Alibaba
BABA
+$10.8M

Sector Composition

Rank Sector Weight
1 Technology 14.1%
2 Consumer Discretionary 11.71%
3 Healthcare 9.05%
4 Industrials 8.79%
5 Financials 6.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CGEM icon
1151
Cullinan Oncology
CGEM
$1.14B
– –
-11,044
Closed -$113K
CLVT icon
1152
Clarivate
CLVT
$1.16B
– –
-13,557
Closed -$127K
CMA
1153
DELISTED
Comerica
CMA
– –
-8,840
Closed -$384K
CMBM
1154
DELISTED
Cambium Networks
CMBM
– –
-17,563
Closed -$311K
CMCSA icon
1155
Comcast
CMCSA
$90B
– –
-12,371
Closed -$469K
CMRE icon
1156
Costamare
CMRE
$1.77B
– –
-11,517
Closed -$108K
CNA icon
1157
CNA Financial
CNA
$14.1B
– –
-5,244
Closed -$205K
COF icon
1158
Capital One
COF
$134B
– –
-2,299
Closed -$221K
COGT icon
1159
Cogent Biosciences
COGT
$7.24B
– –
-26,000
Closed -$281K
COO icon
1160
Cooper Companies
COO
$14.5B
– –
-3,540
Closed -$330K
CRGY icon
1161
Crescent Energy
CRGY
$3.82B
– –
-12,445
Closed -$141K
CRWD icon
1162
CrowdStrike
CRWD
$218B
– –
-8,240
Closed -$283K
CSIQ icon
1163
Canadian Solar
CSIQ
$1.08B
– –
-236,807
Closed -$9.43M
CSTL icon
1164
Castle Biosciences
CSTL
$979M
– –
-23,144
Closed -$526K
CTAS icon
1165
Cintas
CTAS
$81.3B
– –
-21,896
Closed -$2.53M
CTKB icon
1166
Cytek Biosciences
CTKB
$546M
– –
-18,172
Closed -$167K
CVLT icon
1167
Commault Systems
CVLT
$5.61B
– –
-5,337
Closed -$303K
CXM icon
1168
Sprinklr
CXM
$1.61B
– –
-11,650
Closed -$151K
CXT icon
1169
Crane NXT
CXT
$3.07B
– –
-7,025
Closed -$277K
CYBR
1170
DELISTED
CyberArk
CYBR
– –
-1,368
Closed -$202K
DAC icon
1171
Danaos Corp
DAC
$2.56B
– –
-5,075
Closed -$277K
DAVA icon
1172
Endava
DAVA
$156M
– –
-3,382
Closed -$227K
DBA icon
1173
Invesco DB Agriculture Fund
DBA
$1.23B
– –
-20,000
Closed -$409K
DBMF icon
1174
iMGP DBi Managed Futures Strategy ETF
DBMF
$4.15B
– –
-14,000
Closed -$368K
DCBO
1175
Docebo
DCBO
$566M
– –
-16,615
Closed -$676K
45 46
47
48 49

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Prelude Capital Management held 1,512 positions worth $1.54B, down 8.1% from $1.67B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Prelude Capital Management withdrew a net $214M in Q2 2023, closing 425 positions and reducing 289 holdings. Its most notable exit was Li Auto, an estimated $29.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Prelude Capital Management opened a new position in Arconic Corporation worth $7.86M.

  • Prelude Capital Management's largest Q2 2023 buy was Arconic Corporation: 265,725 shares worth $7.86M.
  • Prelude Capital Management added most to IVERIC bio, Inc. Common Stock in Q2 2023, an estimated $10.9M increase.
  • Prelude Capital Management's biggest Q2 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $65.4M.
  • Prelude Capital Management fully exited Li Auto in Q2 2023, selling an estimated $29.4M.
  • Prelude Capital Management's ten largest holdings make up 25% of its $1.54B portfolio in Q2 2023.
  • Prelude Capital Management opened 379 new positions and closed 425 in Q2 2023.
  • Prelude Capital Management's portfolio value fell 8.1% quarter-over-quarter to $1.54B.

Based on Prelude Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.